IL10 and neoplasm: ANG-2, secreted from tumor and vasculature cells, can enhance IL-10 and mannose receptor expression, while decreasing that of TNF-α and IL-12, thereby weakening TAM anti-tumor activity under hypoxic conditions (88, 89).